Submit Abstract for ESPT

Rules for submission

The author is expected to attend the congress and present the poster or oral presentation. The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission. All abstracts must be presented in clear English with accurate grammar and spelling of a quality suitable for publication.

Participants are invited to submit abstract for oral or poster presentations before August 8, 2011. Abstracts can only be submitted online. Poster session is an extremely important part of this event, therefore all participants are encouraged to present their work. All accepted extended abstracts will be published in the book of abstracts. Authors will be notified on the type of presentation (oral or poster) by August 31, 2011. The time limit for oral contribution will be 15 minutes including discussion. The best three posters will be awarded.

Guidelines for submission

• The abstract should be as informative as possible. State specific object of the study and methods used, if pertinent. Summarise results obtained and state conclusions reached.
• Standard abbreviations may be used.
• Abstract should be submitted in good English.
• Abstract should be prepared as a Word file using this template. The template has two columns with top, left and right margins of 2.5 cm and bottom margin of 3 cm. The font is Times New Roman 12 point and Times New Roman 8 point for references, figures and tables captions. Please do not alter the font or margin size. The abstract template includes specific instructions on the format of title, author and affiliations.
• References should be numbered consecutively through the text and a separate list of references must be given. The number of references is limited to 2. Examples of references are listed below.
  • Journal
    1. Suzuki R, Takizawa T, Kuwata Y, Mutoh M, Ishiguro N et al. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. Int. J. Pharm. 2008; 346: 143–150.
  • Book
    2. Gennaro AR, Remington's Pharmaceutical Sciences, XXII, Mack Publishing Company, Easton, PA, 1990.
• Abstract length should not exceed 500 words. Abstracts that do not comply may be rejected or require re-submission.
• Please save your abstract as yourfirstname_yourlastname.doc. Please do not retain the original title of the abstract template.

On-line abstract submission

1. Abstract title (sentence case):
2. Author list:
1. First name: Surname: Presenting author: yes
2. First name: Surname: Presenting author: yes
3. First name: Surname: Presenting author: yes
4. First name: Surname: Presenting author: yes
5. First name: Surname: Presenting author: yes
6. First name: Surname: Presenting author: yes
7. First name: Surname: Presenting author: yes
8. First name: Surname: Presenting author: yes
9. First name: Surname: Presenting author: yes
10. First name: Surname: Presenting author: yes
3. Field of pharmaceutical sciences:	Medicinal Chemistry Pharmaceutical Technology Laboratory Diagnostics Other/Interdisciplinary
4. Key words (maximum 5, comma separated)
5. Conflict of interest statement: All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations that could inappropriately influence, or be perceived to influence, their work. Please type your conflict of interest statement in the text box below. If no conflict exists, authors should state: The authors declare that they have no conflict of interest.
6. Contact person (Presenting author):
First name: Surname:
Title:	Prof Dr Ms Mr
Gender:	femalemale
Company/University:
Department:
Street address:
City:
Postal code:
Country:
Phone:
Fax:
E-mail:
Retype E-mail:
Select your abstract file (max 10mb) (only word document):
Please fill in the captcha form: